Lipopolysaccharide Binding Protein (LBP) (Middle Region) Peptid
LBP
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN979219
Kurzübersicht für Lipopolysaccharide Binding Protein (LBP) (Middle Region) Peptid (ABIN979219)
Target
LBP
(Lipopolysaccharide Binding Protein (LBP))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-LBP antibody (Catalog #: ARP41545_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LBP (Lipopolysaccharide Binding Protein (LBP))
-
Hintergrund
-
LBP is involved in the acute-phase immunologic response to gram-negative bacterial infections. Gram-negative bacteria contain a glycolipid, lipopolysaccharide (LPS), on their outer cell wall. Together with bactericidal permeability-increasing protein (BPI
Alias Symbols: MGC22233, BPIFD2
Protein Interaction Partner: APOA1,CAMP,CD14,CFHR1,RPS21,APOA1,CD14,CFHR1,IRF6
Protein Size: 481 -
Molekulargewicht
- 51 kDa
-
Gen-ID
- 3929
-
NCBI Accession
- NM_004139, NP_004130
-
UniProt
- P18428
Target
-
Sie sind hier:
